Scientists Say a “Doomsday” Variant after Delta Isn’t Likely. But Here’s What’s Possible

Gladstone in the News | By | August 14, 2021 | 1 min read

Up Next

Melanie Ott in her lab at Gladstone Institutes

Article September 25, 2025

Beyond Viruses: Expanding the Fight Against Infectious Diseases

The newly renamed Gladstone Infectious Disease Institute broadens its mission to address global health threats ranging from antibiotic resistance to infections that cause chronic diseases.

Institutional News News Release Cancer COVID-19 Hepatitis C HIV/AIDS Zika Virus Infectious Disease

UCSF Black Health Initiative partners with the San Francisco African American Faith-Based Coalition.

Article August 6, 2025

How Do Vaccines Work?

An in-depth explainer about different types of vaccines and what happens in the body after vaccination.

Gladstone Experts COVID-19 Deep Dive

Kailin Yin and Nadia Roan in the lab at Gladstone Institutes

Article July 22, 2025

Pregnancy, Lactation Shape Immune Response to COVID-19 Vaccine and Infection

Study finds strong immune defenses in pregnant and lactating women, with key benefits that could guide future vaccine design.

News Release Research (Publication) COVID-19 Infectious Disease Roan Lab

Scientists Say a “Doomsday” Variant after Delta Isn’t Likely. But Here’s What’s Possible

Beyond Viruses: Expanding the Fight Against Infectious Diseases

How Do Vaccines Work?

Pregnancy, Lactation Shape Immune Response to COVID-19 Vaccine and Infection

Sign Up for Our Newsletter

Congrats to Jennifer Doudna, winner of the 2020 Nobel Prize in Chemistry!